Results 101 to 110 of about 4,012 (187)

Balance of care activity after EMA recommendation for <i>DPYD</i> gene testing in Galicia. [PDF]

open access: yesFront Pharmacol
Gil-Rodríguez A   +5 more
europepmc   +1 more source

Uso de inteligencia artificial en la predisposición genética a enfermedad crítica por COVID-19: evaluación comparativa de modelos de aprendizaje automático. [PDF]

open access: yesAdv Lab Med
Martin Perez S   +9 more
europepmc   +1 more source

A hidden enemy: Understanding the hemophagocytic syndrome in children under five years of age in a high-complexity institution in southwestern Colombia [PDF]

open access: yesBiomedica
Martínez S   +9 more
europepmc   +1 more source

[Fever after hunting season]. [PDF]

open access: yesAten Primaria, 2022
Martínez-Cisneros S   +2 more
europepmc   +1 more source

[Detection of inborn errors of metabolism: guidelines in Mexico and other countries]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Guerrero-Barrios S   +5 more
europepmc   +1 more source

Deficiencia de 3β-hidroxiesteroide deshidrogenasa: una causa rara de hiperplasia adrenal congénita

open access: yes, 2016
The congenital adrenal hyperplasia corresponds to a group of inherited diseases with enzyme defects that alter the cortisol biosynthesis. The 3β-hydroxysteroid dehydrogenase type 2 deficiency is a rare cause of this defect, where the male genital ...
González Patiño, Angélica   +4 more
core  

Aldehído Deshidrogenasa Humana en una muestra de la población costarricense

open access: yes, 2016
This is an electrophoretic study of ALDH isozymes in post-mortem tissue extracts.Three differente electrophoretic variants of the isosyme ALDH3 were found in the 100 individuals examined. One liver sample showed lack of ALDH1. activity, but it remains unknown whether this is due to genetic mechanisms.
Santisteban, Inés   +1 more
openaire   +2 more sources

Deficiencia de glucosa-6-fosfato deshidrogenasa: De lo clínico a lo bioquímico

open access: yes, 2014
"La deficiencia de Glucosa-6-fosfato deshidrogenasa (G6PD) es la enzimopatía más frecuente, con una prevalencia global del 4,9% y con alrededor de 330 a 400 millones de personas afectadas en el mundo. La G6PD desempeña un papel fundamental en el equilibrio redox intracelular, especialmente en los eritrocitos; en condiciones de estrés oxidativo inducido
Saúl Gómez-Manzo   +11 more
openaire   +1 more source

Home - About - Disclaimer - Privacy